PT  - JOURNAL ARTICLE
AU  - Stubbings, Garrett
AU  - Farrell, Spencer
AU  - Mitnitski, Arnold
AU  - Rockwood, Kenneth
AU  - Rutenberg, Andrew
TI  - Informative Frailty Indices from Binarized Biomarkers
AID  - 10.1101/2020.01.07.20016816
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.01.07.20016816
4099  - http://medrxiv.org/content/early/2020/01/10/2020.01.07.20016816.short
4100  - http://medrxiv.org/content/early/2020/01/10/2020.01.07.20016816.full
AB  - Frailty indices (FI) based on continuous valued health data, such as obtained from blood and urine tests, have been shown to be predictive of adverse health outcomes. However, creating FI from such biomarker data requires a binarization treatment that is difficult to standardize across studies. In this work, we explore a “quantile” methodology for the generic treatment of biomarker data that allows us to construct an FI without preexisting medical knowledge (i.e. risk thresholds) of the included biomarkers. We show that our quantile approach performs as well as, or even slightly better than, established methods for the National Health and Nutrition Examination Survey (NHANES) and the Canadian Study of Health and Aging (CSHA) data sets. Furthermore, we show that our approach is robust to cohort effects within studies as compared to other data-based methods. The success of our binarization approaches provides insight into the robustness of the FI as a health measure, the upper limits of the FI observed in various data sets, and highlights general difficulties in obtaining absolute scales for comparing FI between studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNone.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available.